TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Chlorhexidine Gluconate vs Povidone-Iodine Vaginal Cleansing Solution Prior to Cesarean Delivery: A Randomized Comparator Controlled Trial
Brief Summary: Endometritis, an infection of the uterus in the postpartum period, has been shown to complicate the postoperative course of a cesarean delivery in 6% to 27% of cases. Vaginal cleansing prior to cesarean delivery has been shown to minimize the presence of micro-organisms and risk of infection. Although povidone-iodine is the most commonly used anti-septic for surgical preparation of the vagina, it is not an ideal agent due to it's diminished efficacy in acidic vaginal pH and in the presence of blood. Chlorhexidine gluconate, on the other hand, has demonstrated superior disinfectant properties in several clinical trials, as compared to povidone iodine. In this randomized, comparator controlled, study the investigators will be comparing chlorhexidine gluconate vs povidone iodine for intrapartum vaginal preparation in women undergoing non-emergent cesarean delivery.


Options:
A: Arm Label: Chlorhexidine gluconate vaginal scrub; Type: EXPERIMENTAL; Interventions: Drug: EZ scrub vaginal chlorhexidine 4% solution | Arm Label: Povidone-iodine vaginal scrub; Type: ACTIVE_COMPARATOR; Interventions: Drug: 10% provodine-iodine vaginal preparation | Intervention Type: DRUG; Name: EZ scrub vaginal chlorhexidine 4% solution; Assigned to Arm(s): Chlorhexidine gluconate vaginal scrub | Intervention Type: DRUG; Name: 10% provodine-iodine vaginal preparation; Assigned to Arm(s): Povidone-iodine vaginal scrub
B: Arm Label: Povidone Iodine; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Povidone Iodine | Arm Label: Chlorhexidine gluconate; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Chlorhexidine gluconate | Intervention Type: PROCEDURE; Name: Povidone Iodine; Assigned to Arm(s): Povidone Iodine | Intervention Type: PROCEDURE; Name: Chlorhexidine gluconate; Assigned to Arm(s): Chlorhexidine gluconate
C: Arm Label: Chlorhexidine - Isopropyl alcohol; Type: EXPERIMENTAL; Interventions: Drug: Chlorhexidine - Isopropyl alcohol | Arm Label: Povidone-Iodine Scrub and Paint; Type: EXPERIMENTAL; Interventions: Drug: Povidone-Iodine Scrub and Paint | Intervention Type: DRUG; Name: Chlorhexidine - Isopropyl alcohol; Assigned to Arm(s): Chlorhexidine - Isopropyl alcohol | Intervention Type: DRUG; Name: Povidone-Iodine Scrub and Paint; Assigned to Arm(s): Povidone-Iodine Scrub and Paint
D: Arm Label: Iodine-alcohol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Iodine-alcohol | Arm Label: Chlorhexidine-alcohol; Type: EXPERIMENTAL; Interventions: Drug: Chlorhexidine-alcohol | Intervention Type: DRUG; Name: Iodine-alcohol; Assigned to Arm(s): Iodine-alcohol | Intervention Type: DRUG; Name: Chlorhexidine-alcohol; Assigned to Arm(s): Chlorhexidine-alcohol

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Early Progressive Feeding in Human-Milk Fed Extremely Preterm Infants: A Randomized Trial
Brief Summary: To test the hypothesis that progressive feeding without minimal enteral feeding (MEF) compared to progressive feeding preceded by a 4-day course of MEF will result in an increased number of days alive on full enteral feeding in the first 28 days after birth in extremely preterm infants receiving human milk.


Options:
A: Arm Label: probiotics group; Type: EXPERIMENTAL; Interventions: Dietary Supplement: probiotics | Arm Label: control group; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: glucose solution | Intervention Type: DIETARY_SUPPLEMENT; Name: probiotics; Assigned to Arm(s): probiotics group | Intervention Type: DIETARY_SUPPLEMENT; Name: glucose solution; Assigned to Arm(s): control group
B: Arm Label: probiotic group; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Lactobacillus reuteri | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus reuteri; Assigned to Arm(s): probiotic group | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Progressive Feeding without MEF; Type: EXPERIMENTAL; Interventions: Other: Progressive Feeding without MEF | Arm Label: Progressive Feeding with MEF; Type: ACTIVE_COMPARATOR; Interventions: Other: Progressive Feeding with MEF | Intervention Type: OTHER; Name: Progressive Feeding without MEF; Assigned to Arm(s): Progressive Feeding without MEF | Intervention Type: OTHER; Name: Progressive Feeding with MEF; Assigned to Arm(s): Progressive Feeding with MEF
D: Arm Label: group 1; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: nutrition | Arm Label: group 2; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: nutrition | Intervention Type: DIETARY_SUPPLEMENT; Name: nutrition; Assigned to Arm(s): group 1, group 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation in Real Life Conditions of Sacubitril-valsartan Combination in Patients With Chronic Heart Failure and Sleep Apnea Syndrome
Brief Summary: Chronic Heart Failure (CHF) is a frequent pathology burdened with mortality and significant morbidity. Sleep apnea syndrome (SAS) is frequently associated with CHF in 20% to 75% of cases. Treatment of SAS is however inconsistently associated with a decline in the morbidity and mortality. To date, the CHF medical treatments have been reported to be inconsistently efficient in the treatment of SAS.

SACUBITRIL-VALSARTAN (ENTRESTO®) is a new treatment of CHF recently indicated class I, level B in the recent European Society of Cardiology (ESC) guidelines 2016 on CHF. PARADIGM-HF trial demonstrated that morbidity and mortality can be improved with SACUBITRIL-VALSARTAN. In comparison to enalapril, it reduced the occurrence of cardiovascular death or hospitalisation for CHF by 20% with a 16% reduction in all-cause mortality.

The purpose of the research is the evaluation of SACUBITRIL-VALSARTAN combination in CHF patients presenting sleep apnea syndrome. A three months real life observational trial is performed. A measure of the Apnea Hypopnea Index is realised before and after 3 months of SACUBITRIL-VALSARTAN treatment. A concomitant evaluation of cardiological and quality of life parameters is realized.


Options:
A: Arm Label: Treatment Group; Type: EXPERIMENTAL; Interventions: Device: Treatment Group (transvenous stimulation of the phrenic nerve) | Arm Label: Control group; Type: OTHER; Interventions: Device: Control Group (Optimal Medical Therapy) | Intervention Type: DEVICE; Name: Treatment Group (transvenous stimulation of the phrenic nerve); Assigned to Arm(s): Treatment Group | Intervention Type: DEVICE; Name: Control Group (Optimal Medical Therapy); Assigned to Arm(s): Control group
B: Arm Label: Treatment Group; Type: ACTIVE_COMPARATOR; Interventions: Device: Europe: AutoSet CS (USA: VPAP Adapt SV) | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Europe: AutoSet CS (USA: VPAP Adapt SV); Assigned to Arm(s): Treatment Group
C: Arm Label: SACUBITRIL - VALSARTAN; Type: EXPERIMENTAL; Interventions: Drug: SACUBITRIL - VALSARTAN (formerly LCZ696, ENTRESTO®) | Intervention Type: DRUG; Name: SACUBITRIL - VALSARTAN (formerly LCZ696, ENTRESTO®); Assigned to Arm(s): SACUBITRIL - VALSARTAN
D: Arm Label: #1 (Acetazolamide-placebo); Type: EXPERIMENTAL; Interventions: Drug: Acetazolamide-placebo | Arm Label: #2 (Placebo-acetazolamide); Type: EXPERIMENTAL; Interventions: Drug: Placebo-acetazolamide | Intervention Type: DRUG; Name: Acetazolamide-placebo; Assigned to Arm(s): #1 (Acetazolamide-placebo) | Intervention Type: DRUG; Name: Placebo-acetazolamide; Assigned to Arm(s): #2 (Placebo-acetazolamide)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Web-Based CBT for Women Veterans With PTSD
Brief Summary: The purpose of this study is to evaluate an online PTSD intervention that was adapted for women Veterans, called DElivery of Self TRaining and Education for Stressful Situations-Women Veterans version (DESTRESS-WV). The intervention consists of structured online sessions as well as weekly brief phone calls for additional support with a study coach. Women Veterans with PTSD who are eligible will be randomized to receive either DESTRESS-WV or phone monitoring only for 8 weeks. Participants will be assessed immediately post-treatment as well as at 12 and 24 weeks post-treatment. Investigators hypothesize that participants randomly assigned to DESTRESS-WV will have a greater decrease in severity of PTSD symptoms compared to those randomly assigned to phone monitoring only.


Options:
A: Arm Label: Fall prevention standard of care; Type: OTHER; Interventions: Other: Evidence-based tailored fall prevention | Arm Label: Control; Type: OTHER; Interventions: Other: Usual care | Intervention Type: OTHER; Name: Evidence-based tailored fall prevention; Assigned to Arm(s): Fall prevention standard of care | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Control
B: Arm Label: DESTRESS-WV; Type: EXPERIMENTAL; Interventions: Behavioral: DESTRESS-WV | Arm Label: Phone Monitoring; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Phone Monitoring | Intervention Type: BEHAVIORAL; Name: DESTRESS-WV; Assigned to Arm(s): DESTRESS-WV | Intervention Type: BEHAVIORAL; Name: Phone Monitoring; Assigned to Arm(s): Phone Monitoring
C: Arm Label: DESTRESS-PC; Type: EXPERIMENTAL; Interventions: Behavioral: DESTRESS-PC | Arm Label: OUC; Type: ACTIVE_COMPARATOR; Interventions: Other: Optimized Usual Primary Care PTSD treatment | Intervention Type: BEHAVIORAL; Name: DESTRESS-PC; Assigned to Arm(s): DESTRESS-PC | Intervention Type: OTHER; Name: Optimized Usual Primary Care PTSD treatment; Assigned to Arm(s): OUC
D: Arm Label: Cognitive behavioral program; Type: EXPERIMENTAL; Interventions: Behavioral: an in-home cognitive behavioral program | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: an in-home cognitive behavioral program; Assigned to Arm(s): Cognitive behavioral program

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Coordinated PCP-Cardiologist Telemedicine Model (PCTM) in China's Community Hypertension Care: Study Protocol for a Randomized Controlled Trial
Brief Summary: This three arm study is to compare the effects of a coordinated PCP-Cardiologist Telemedicine Model (PCTM) with usual care and self-care in community hypertension management in China.


Options:
A: Arm Label: Pharmacist-Bidirectional Texting Group; Type: EXPERIMENTAL; Interventions: Other: Experimental: Pharmacist-Bidirectional Texting Group | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Active Comparator: Control Group | Intervention Type: OTHER; Name: Experimental: Pharmacist-Bidirectional Texting Group; Assigned to Arm(s): Pharmacist-Bidirectional Texting Group | Intervention Type: OTHER; Name: Active Comparator: Control Group; Assigned to Arm(s): Control Group
B: Arm Label: Usual care (UC); Type: PLACEBO_COMPARATOR; Interventions: Other: Usual care | Arm Label: Self-management; Type: EXPERIMENTAL; Interventions: Device: Self-management | Arm Label: PCTM intervention; Type: EXPERIMENTAL; Interventions: Other: PCTM intervention | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual care (UC) | Intervention Type: DEVICE; Name: Self-management; Assigned to Arm(s): Self-management | Intervention Type: OTHER; Name: PCTM intervention; Assigned to Arm(s): PCTM intervention
C: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Pharmacist CVD | Arm Label: Arm 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Pharmacist CVD; Assigned to Arm(s): Arm 1
D: Arm Label: Home blood pressure telemonitoring; Type: N/A; Interventions: N/A | Arm Label: Conventional blood pressure measurement; Type: N/A; Interventions: N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Coordinated PCP-Cardiologist Telemedicine Model (PCTM) in China's Community Hypertension Care: Study Protocol for a Randomized Controlled Trial
Brief Summary: This three arm study is to compare the effects of a coordinated PCP-Cardiologist Telemedicine Model (PCTM) with usual care and self-care in community hypertension management in China.


Options:
A: Arm Label: Pre-Implementation Cohort; Type: N/A; Interventions: Other: Usual Care | Arm Label: Post-Implementation Cohort; Type: N/A; Interventions: Other: Blended Telemedicine-Based Integrated Care | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Pre-Implementation Cohort | Intervention Type: OTHER; Name: Blended Telemedicine-Based Integrated Care; Assigned to Arm(s): Post-Implementation Cohort
B: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Procedure: Store and forward teledermatology | Arm Label: Arm 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Store and forward teledermatology; Assigned to Arm(s): Arm 1
C: Arm Label: Experimental; Type: N/A; Interventions: Other: CAPRI | Arm Label: Control; Type: N/A; Interventions: N/A | Intervention Type: OTHER; Name: CAPRI; Assigned to Arm(s): Experimental
D: Arm Label: Usual care (UC); Type: PLACEBO_COMPARATOR; Interventions: Other: Usual care | Arm Label: Self-management; Type: EXPERIMENTAL; Interventions: Device: Self-management | Arm Label: PCTM intervention; Type: EXPERIMENTAL; Interventions: Other: PCTM intervention | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual care (UC) | Intervention Type: DEVICE; Name: Self-management; Assigned to Arm(s): Self-management | Intervention Type: OTHER; Name: PCTM intervention; Assigned to Arm(s): PCTM intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Coordinated PCP-Cardiologist Telemedicine Model (PCTM) in China's Community Hypertension Care: Study Protocol for a Randomized Controlled Trial
Brief Summary: This three arm study is to compare the effects of a coordinated PCP-Cardiologist Telemedicine Model (PCTM) with usual care and self-care in community hypertension management in China.


Options:
A: Arm Label: telemedicine; Type: EXPERIMENTAL; Interventions: Behavioral: telemedicine | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: telemedicine; Assigned to Arm(s): telemedicine
B: Arm Label: A, 1, I; Type: EXPERIMENTAL; Interventions: Device: Home blood pressure tele-management system. | Arm Label: A, 2, I; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care. | Intervention Type: DEVICE; Name: Home blood pressure tele-management system.; Assigned to Arm(s): A, 1, I | Intervention Type: OTHER; Name: Usual care.; Assigned to Arm(s): A, 2, I
C: Arm Label: Usual care (UC); Type: PLACEBO_COMPARATOR; Interventions: Other: Usual care | Arm Label: Self-management; Type: EXPERIMENTAL; Interventions: Device: Self-management | Arm Label: PCTM intervention; Type: EXPERIMENTAL; Interventions: Other: PCTM intervention | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual care (UC) | Intervention Type: DEVICE; Name: Self-management; Assigned to Arm(s): Self-management | Intervention Type: OTHER; Name: PCTM intervention; Assigned to Arm(s): PCTM intervention
D: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Device: "COMBINED STRATEGY" | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: "COMBINED STRATEGY"; Assigned to Arm(s): Intervention group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of Single, Double and Triple Dose Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis: a Pilot Study
Brief Summary: Introduction: Up to the present, have been few studies with pentamidine in the Americas; and there is no consensus regarding the dose used.

Objectives: To evaluate the use of pentamidine in single dose, double and triplo in the treatment of cutaneous leishmaniasis.

Methods: Clinical trial of phase II pilot study with 159 patients. Pentamidine will be used at a dose of 7 mg/kg, in three arms: single dose, double dose and triple dose. They will be also assessed the safety and adverse effects. The sic will be reviewed one, two and six months after the end of the treatments.


Options:
A: Intervention Type: BIOLOGICAL; Name: Leish-111f + MPL-SE vaccine; Assigned to Arm(s): N/A
B: Arm Label: Group 1 - Paromomycin cream; Type: EXPERIMENTAL; Interventions: Drug: Paromomycin Sulfate | Arm Label: Group 2. Local Injectable Pentamidine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pentamidine Isethionate | Arm Label: Group 3. Vehicle control; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Paromomycin Sulfate; Assigned to Arm(s): Group 1 - Paromomycin cream | Intervention Type: DRUG; Name: Pentamidine Isethionate; Assigned to Arm(s): Group 2. Local Injectable Pentamidine | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Group 3. Vehicle control
C: Arm Label: Single dose of Pentamidine; Type: EXPERIMENTAL; Interventions: Drug: Single dose of Pentamidine | Arm Label: Two doses of Pentamidine; Type: EXPERIMENTAL; Interventions: Drug: Two doses of Pentamidine | Arm Label: Three doses of Pentamidine; Type: EXPERIMENTAL; Interventions: Drug: Three doses of Pentamidine | Intervention Type: DRUG; Name: Single dose of Pentamidine; Assigned to Arm(s): Single dose of Pentamidine | Intervention Type: DRUG; Name: Two doses of Pentamidine; Assigned to Arm(s): Two doses of Pentamidine | Intervention Type: DRUG; Name: Three doses of Pentamidine; Assigned to Arm(s): Three doses of Pentamidine
D: Intervention Type: DRUG; Name: Anti-helminthic; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: meglumine antimony; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Multicenter, Randomized Double-blind Study Examining the Safety and Efficacy of Using the Evoke™ Spinal Cord Stimulator (SCS) System With Feedback to Treat Patients With Chronic Pain of the Trunk and/or Limbs.
Brief Summary: The purpose of this study is to evaluate the safety and efficacy of the Saluda Medical Evoke SCS System with feedback control to treat chronic pain of the trunk and/or limbs.


Options:
A: Arm Label: Evoke SCS with Feedback; Type: EXPERIMENTAL; Interventions: Device: Evoke Spinal Cord Stimulator (SCS) System | Arm Label: Evoke SCS with Conventional; Type: ACTIVE_COMPARATOR; Interventions: Device: Evoke Spinal Cord Stimulator (SCS) System | Intervention Type: DEVICE; Name: Evoke Spinal Cord Stimulator (SCS) System; Assigned to Arm(s): Evoke SCS with Conventional, Evoke SCS with Feedback
B: Arm Label: HF/TCS/BURST; Type: EXPERIMENTAL; Interventions: Device: Precision Spectra™ system | Arm Label: HF/BURST/TCS; Type: EXPERIMENTAL; Interventions: Device: Precision Spectra™ system | Arm Label: BURST/HF/TCS; Type: EXPERIMENTAL; Interventions: Device: Precision Spectra™ system | Arm Label: BURST/TCS/HF; Type: EXPERIMENTAL; Interventions: Device: Precision Spectra™ system | Arm Label: TCS/BURST/HF; Type: EXPERIMENTAL; Interventions: Device: Precision Spectra™ system | Arm Label: TCS/HF/BURST; Type: EXPERIMENTAL; Interventions: Device: Precision Spectra™ system | Intervention Type: DEVICE; Name: Precision Spectra™ system; Assigned to Arm(s): BURST/HF/TCS, BURST/TCS/HF, HF/BURST/TCS, HF/TCS/BURST, TCS/BURST/HF, TCS/HF/BURST
C: Arm Label: EES on; Type: EXPERIMENTAL; Interventions: Device: EES on | Arm Label: EES off; Type: PLACEBO_COMPARATOR; Interventions: Device: EES off | Intervention Type: DEVICE; Name: EES on; Assigned to Arm(s): EES on | Intervention Type: DEVICE; Name: EES off; Assigned to Arm(s): EES off
D: Arm Label: Spinal Cord Stimulation (SCS); Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal Cord Stimulation | Arm Label: Conventional Medical Management (CMM); Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional Medical Management | Intervention Type: DEVICE; Name: Spinal Cord Stimulation; Assigned to Arm(s): Spinal Cord Stimulation (SCS) | Intervention Type: OTHER; Name: Conventional Medical Management; Assigned to Arm(s): Conventional Medical Management (CMM)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Buying Time: Improving Sleep to Promote Cognitive Function in Older Adults
Brief Summary: The purpose of this study is to investigate whether a comprehensive group education combined with a lifestyle "activation" program that includes (a) sleep hygiene course, (b) physical activity promotion, and (c) bright light therapy, can improve both sleep quality and cognitive function among 96 community-dwelling older adults.


Options:
A: Intervention Type: DRUG; Name: galantamine; Assigned to Arm(s): N/A
B: Arm Label: Modafinil; Type: EXPERIMENTAL; Interventions: Drug: modafinil | Intervention Type: DRUG; Name: modafinil; Assigned to Arm(s): Modafinil
C: Arm Label: Treatment Group; Type: EXPERIMENTAL; Interventions: Device: GammaSense Stimulation System (Active Settings) | Arm Label: Control Group; Type: SHAM_COMPARATOR; Interventions: Device: GammaSense Stimulation System (Sham Settings) | Intervention Type: DEVICE; Name: GammaSense Stimulation System (Active Settings); Assigned to Arm(s): Treatment Group | Intervention Type: DEVICE; Name: GammaSense Stimulation System (Sham Settings); Assigned to Arm(s): Control Group
D: Arm Label: Life Style and Sleep Group; Type: EXPERIMENTAL; Interventions: Behavioral: Life Style and Sleep Intervention | Arm Label: Wait-list Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Life Style and Sleep Intervention; Assigned to Arm(s): Life Style and Sleep Group

Answer: D